Home NDC 41250-035 MEIJER
Product NDC 41250-035
11-digit product format 412500035
Labeler code 41250
Product ID 41250-035_499610fd-adb3-411e-92f2-c9596916b50a
Type HUMAN OTC DRUG
Nonproprietary name AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE
Dosage form LOTION
Route TOPICAL
Labeler Meijer Distribution Inc
Application part352
Marketing category OTC MONOGRAPH NOT FINAL
Marketing start 2013-07-12
Marketing end 0000-00-00
Substance AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Active strength 3 g/100g; g/100g; g/100g; g/100g; g/100g
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 41250-035-22 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 41250-035-22 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 41250-035-22 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 41250-035-22 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 41250-035-22 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 41250-035-22 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 41250-035-22 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 41250-035-22 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 41250-035-22 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 41250-035-22 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 41250-035-22 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 41250-035-22 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 41250-035-22 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 41250-035-22 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 41250-035-22 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 41250-035-22 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 41250-035-22 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 41250-035-22 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 41250-035-22 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 41250-035-22 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 41250-035-22 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 41250-035-22 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 41250-035-22 MEIJER 85 g in 1 BOTTLE LOTION 85 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AVOBENZONE ACTIVE INGREDIENT G63QQF2NOX MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 HOMOSALATE ACTIVE INGREDIENT V06SV4M95S MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OCTISALATE ACTIVE INGREDIENT 4X49Y0596W MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OCTOCRYLENE ACTIVE INGREDIENT 5A68WGF6WM MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OXYBENZONE ACTIVE INGREDIENT 95OOS7VE0Y MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 AVOBENZONE ACTIVE MOIETY G63QQF2NOX MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 HOMOSALATE ACTIVE MOIETY V06SV4M95S MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OCTISALATE ACTIVE MOIETY 4X49Y0596W MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OCTOCRYLENE ACTIVE MOIETY 5A68WGF6WM MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 OXYBENZONE ACTIVE MOIETY 95OOS7VE0Y MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 CAPRYLYL TRISILOXANE INACTIVE INGREDIENT Q95M2P1KJL MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 CHLORPHENESIN INACTIVE INGREDIENT I670DAL4SZ MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 ETHYLHEXYL STEARATE INACTIVE INGREDIENT EG3PA2K3K5 MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 GLYCYRRHIZINATE DIPOTASSIUM INACTIVE INGREDIENT CA2Y0FE3FX MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 PEG-100 STEARATE INACTIVE INGREDIENT YD01N1999R MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 TRIDECETH-6 INACTIVE INGREDIENT 3T5PCR2H0C MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 WATER INACTIVE INGREDIENT 059QF0KO0R MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 YELLOW WAX INACTIVE INGREDIENT 2ZA36H0S2V MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 41250-035 MEIJER (AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE) LOTION [MEIJER DISTRIBUTION INC ] 1 Legacy NDC, 1 package rows 20130716_4183dad4-3ac3-4d9d-86ef-9c5db1529df2.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 41250-035-22 41250003522 85 g in 1 BOTTLE 85 g Historical